Embryonic Stem Cells Work

HALF A MIND:©2002, The National Academy of SciencesLesioned brains 16 weeks after embryonic stem cell transplant stain positive for tyrosine hydroxylase (TH: green), dopamine transporter (DAT: red), and aromatic amino acid decar-boxylase (AADC: blue) in an overlaid image. Bar equals 25 μm.Since drawing the attention of scientists, ethicists, and policymakers, stem cells have not lost their place as one of the most promising yet controversial scientific discoveries of the 20th century.

Written byMaria Anderson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

©2002, The National Academy of Sciences

Lesioned brains 16 weeks after embryonic stem cell transplant stain positive for tyrosine hydroxylase (TH: green), dopamine transporter (DAT: red), and aromatic amino acid decar-boxylase (AADC: blue) in an overlaid image. Bar equals 25 μm.

Since drawing the attention of scientists, ethicists, and policymakers, stem cells have not lost their place as one of the most promising yet controversial scientific discoveries of the 20th century. Scientists admit that they still know very little about how these undifferentiated pluripotent precursors work, but they're looking to develop a more sophisticated view, one that will unlock stem cells' therapeutic potential. Many regard embryonic stem cell (ESC) transplant as the ideal therapy for treating conditions such as Parkinson disease and diabetes, since they could replace malfunctioning cells, but so far the results in animal models have been mixed. Indeed, some groups have published different interpretations of seemingly similar ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA